Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study-Reference-Cited by-同舟云学术

Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study

Published:2012-11 Issue:11 Volume:13 Page:1096-1104
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Kantarjian Hagop,Faderl Stefan,Garcia-Manero Guillermo,Luger Selina,Venugopal Parameswaran,Maness Lori,Wetzler Meir,Coutre Steven,Stock Wendy,Claxton David,Goldberg Stuart L,Arellano Martha,Strickland Stephen A,Seiter Karen,Schiller Gary,Jabbour Elias,Chiao Judy,Plunkett William

Funder

National Cancer Institute, Department of Health and Human Services

Publisher

Elsevier BV

Subject

Oncology

Reference23 articles.

1. Progress in the treatment of acute myeloid leukemia;Ravandi;Cancer,2007

2. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome;Kantarjian;Cancer,2006

3. Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia;Kantarjian;Blood,2010

4. Questions regarding frontline therapy of acute myeloid leukemia;Kantarjian;Cancer,2010

5. Therapy for elderly patients with acute myeloid leukemia: a problem in search of solutions;Kantarjian;Cancer,2007

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of the Geriatric 8 score alone and included with genetic risk group in older adults with acute myeloid leukemia;Journal of Geriatric Oncology;2023-09

2. Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia;Cancer;2023-01-30

3. Venetoclax in combination with nucleoside analogs in acute myelogenous leukemia;Current Opinion in Oncology;2022-07-16

4. Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells;Journal of Experimental & Clinical Cancer Research;2021-10-12

5. Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells;2021-07-20